FORM DEF 14A

Company

Eloxx Pharmaceuticals, Inc.

Filed

October 31, 2022

Period of Report

November 30, 2022

Accession Number

0001140361-22-039123

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →